Celgene shareholders are parsing blurry photos in search of a payday

On Wednesday, former Celgene shareholders experienced the biotech version of that magical thinking when investors on the Internet passed around blurry photos of what may or may not be FDA inspectors walking into what may or may not be a Celgene manufacturing plant.